Read more: Recent acquisitions help Numinus bolster revenue 240 per cent year-over-year Read more: Numinus approved to study ayahuasca and San Pedro in Canada Robison is also an adjunct professor at the University of Utah and Brigham Young University. Thielking was most recently Chief Scientific Officer at Novamind and is certified in psychiatry, hospice and palliative medicine and integrative medicine. ![]() He is the principal investigator for a psilocybin-enhanced group psychotherapy intervention for cancer patients with depression and a researcher on a study for ketamine-assisted psychotherapy for opioid use disorder. He has extensive experience in creating group therapy interventions for patients with serious illnesses and has successfully integrated ketamine-assisted psychotherapy services within an academic outpatient oncology clinic for cancer patients with depression. Thielking was also the director of psycho-oncology at the University of Utah Huntsman Cancer Institute for five years and previously an associate professor in the department of psychiatry at the University of Utah. Numinus also announced that Michael Tan –who was hired in 2019– has been promoted to President and Chief Operating Officer and will oversee all operations and lead strategic directives to drive revenue growth. The company said that due to the increased medical and research expertise added to Numinus’ expanded executive team, Evan Wood, Chief Medical Officer, will continue in his role in a reduced capacity, “in order to enable him to maintain his important advocacy, clinical and teaching work.” Tan has been instrumental in Numinus’ growth, and joined the Company in 2019. ![]() Wood will be involved less but continue at Numinus over the long term and will continue as the company’s Chief Medical Officer through the integration of Novamind. Novamind clinics in Utah and Arizona will continue to operate as their current brand until later this year, at which point all locations will be rebranded to reflect the Numinus brand. “This acquisition elevates our collective service offering, and we look forward to helping an even greater number of people access effective and safe treatments to support mental wellness,” Numinus CEO Payton Nyquvest said.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |